| 000 | 01603 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513130223.0 | ||
| 264 | 0 | _c19971114 | |
| 008 | 199711s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.49.4.1133 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShinotoh, H | |
| 245 | 0 | 0 |
_aFluorodopa and raclopride PET analysis of patients with Machado-Joseph disease. _h[electronic resource] |
| 260 |
_bNeurology _cOct 1997 |
||
| 300 |
_a1133-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCaudate Nucleus _xmetabolism |
| 650 | 0 | 4 |
_aCerebellum _xmetabolism |
| 650 | 0 | 4 |
_aDihydroxyphenylalanine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDopamine Antagonists _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMachado-Joseph Disease _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParkinson Disease _xdiagnostic imaging |
| 650 | 0 | 4 |
_aPutamen _xmetabolism |
| 650 | 0 | 4 | _aRaclopride |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aSalicylamides _xmetabolism |
| 650 | 0 | 4 | _aTissue Distribution |
| 650 | 0 | 4 | _aTomography, Emission-Computed |
| 700 | 1 | _aThiessen, B | |
| 700 | 1 | _aSnow, B J | |
| 700 | 1 | _aHashimoto, S | |
| 700 | 1 | _aMacLeod, P | |
| 700 | 1 | _aSilveira, I | |
| 700 | 1 | _aRouleau, G A | |
| 700 | 1 | _aSchulzer, M | |
| 700 | 1 | _aCalne, D B | |
| 773 | 0 |
_tNeurology _gvol. 49 _gno. 4 _gp. 1133-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.49.4.1133 _zAvailable from publisher's website |
| 999 |
_c9311294 _d9311294 |
||